Regulation of Trail Receptor Expression in Human Melanoma View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2005

AUTHORS

Peter Hersey , Si Yi Zhang , Xu Dong Zhang

ABSTRACT

In previous studies we have shown that the level of expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor R2 was a major determinant of the sensitivity of melanoma cell lines to TRAIL-induced apoptosis. Transcriptional events regulating TRAIL death receptor expression have been the focus of much study, but our investigations point to a more important role for posttranscriptional events in regulation of TRAIL death receptors. First, although there was a wide variation in TRAIL-R2 expression between melanoma cell lines, this did not correlate with mRNA expression assessed by real-time PCR. Similarly, early passage primary cultures from patients tended to have low TRAIL-R2 protein expression compared to cells in later passage cultures, even though TRAIL-R2 mRNA expression was similar in early and late passages. Second, generation of TRAIL-resistant melanoma lines by culture in TRAIL was also associated with decreased expression of TRAIL-R2 protein, but TRAIL-R2 mRNA levels were similar to those in parental high-TRAIL-R2 expressing cells. The latter model was used to explore post-transcriptional regulation of TRAIL-R2. Expression from a luciferase reporter gene construct with the 3′ untranslated region (UTR) (but not the 5′ UTR) of TRAIL-R2 was suppressed when transfected into the TRAIL-selected (resistant) melanoma lines and in early passage (resistant) primary melanoma cultures. RNA gel shift assays demonstrated protein(s) binding to the 3′UTR but not the 5′UTR of TRAIL-R2 mRNA. These results suggest that TRAIL-R2 expression in melanoma cell lines is determined in large part by posttranscriptional events and that protein(s) binding to the 3′UTR region of TRAIL-R2 mRNA may play a key role in this regulation. Decoy receptors appeared to play little or no role in regulation of TRAIL-mediated apoptosis of melanoma. More... »

PAGES

175-187

Identifiers

URI

http://scigraph.springernature.com/pub.10.1385/1-59259-851-x:175

DOI

http://dx.doi.org/10.1385/1-59259-851-x:175

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006126383


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Genetics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "Immunology and Oncology Unit, David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hersey", 
        "givenName": "Peter", 
        "id": "sg:person.01073667716.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Si Yi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia", 
          "id": "http://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Xu Dong", 
        "id": "sg:person.01210116316.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2005", 
    "datePublishedReg": "2005-01-01", 
    "description": "In previous studies we have shown that the level of expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor R2 was a major determinant of the sensitivity of melanoma cell lines to TRAIL-induced apoptosis. Transcriptional events regulating TRAIL death receptor expression have been the focus of much study, but our investigations point to a more important role for posttranscriptional events in regulation of TRAIL death receptors. First, although there was a wide variation in TRAIL-R2 expression between melanoma cell lines, this did not correlate with mRNA expression assessed by real-time PCR. Similarly, early passage primary cultures from patients tended to have low TRAIL-R2 protein expression compared to cells in later passage cultures, even though TRAIL-R2 mRNA expression was similar in early and late passages. Second, generation of TRAIL-resistant melanoma lines by culture in TRAIL was also associated with decreased expression of TRAIL-R2 protein, but TRAIL-R2 mRNA levels were similar to those in parental high-TRAIL-R2 expressing cells. The latter model was used to explore post-transcriptional regulation of TRAIL-R2. Expression from a luciferase reporter gene construct with the 3\u2032 untranslated region (UTR) (but not the 5\u2032 UTR) of TRAIL-R2 was suppressed when transfected into the TRAIL-selected (resistant) melanoma lines and in early passage (resistant) primary melanoma cultures. RNA gel shift assays demonstrated protein(s) binding to the 3\u2032UTR but not the 5\u2032UTR of TRAIL-R2 mRNA. These results suggest that TRAIL-R2 expression in melanoma cell lines is determined in large part by posttranscriptional events and that protein(s) binding to the 3\u2032UTR region of TRAIL-R2 mRNA may play a key role in this regulation. Decoy receptors appeared to play little or no role in regulation of TRAIL-mediated apoptosis of melanoma.", 
    "editor": [
      {
        "familyName": "El-Deiry", 
        "givenName": "Wafik S.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1385/1-59259-851-x:175", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-58829-172-1", 
        "978-1-59259-851-9"
      ], 
      "name": "Death Receptors in Cancer Therapy", 
      "type": "Book"
    }, 
    "keywords": [
      "TRAIL-R2 mRNA", 
      "melanoma cell lines", 
      "posttranscriptional events", 
      "TRAIL-R2 expression", 
      "untranslated region", 
      "cell lines", 
      "post-transcriptional regulation", 
      "RNA gel shift assays", 
      "gel shift assays", 
      "regulation of TRAIL", 
      "luciferase reporter gene", 
      "apoptosis of melanoma", 
      "TRAIL-R2", 
      "transcriptional events", 
      "TRAIL death receptors", 
      "level of expression", 
      "reporter gene", 
      "shift assays", 
      "death receptor expression", 
      "early passage primary cultures", 
      "death receptors", 
      "melanoma lines", 
      "real-time PCR", 
      "late passage cultures", 
      "mRNA expression", 
      "TRAIL death receptor expression", 
      "protein expression", 
      "late passages", 
      "regulation", 
      "passage cultures", 
      "decreased expression", 
      "expressing cells", 
      "expression", 
      "mRNA levels", 
      "TRAIL receptor expression", 
      "human melanoma", 
      "apoptosis", 
      "receptor expression", 
      "decoy receptor", 
      "primary cultures", 
      "mRNA", 
      "key role", 
      "melanoma cultures", 
      "important role", 
      "major determinant", 
      "cells", 
      "receptors", 
      "genes", 
      "lines", 
      "role", 
      "protein", 
      "culture", 
      "primary melanoma cultures", 
      "PCR", 
      "previous studies", 
      "trails", 
      "region", 
      "assays", 
      "large part", 
      "events", 
      "levels", 
      "wide variation", 
      "receptor R2", 
      "melanoma", 
      "variation", 
      "determinants", 
      "study", 
      "patients", 
      "generation", 
      "passage", 
      "part", 
      "sensitivity", 
      "results", 
      "investigation", 
      "focus", 
      "R2", 
      "latter model", 
      "model"
    ], 
    "name": "Regulation of Trail Receptor Expression in Human Melanoma", 
    "pagination": "175-187", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006126383"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1385/1-59259-851-x:175"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1385/1-59259-851-x:175", 
      "https://app.dimensions.ai/details/publication/pub.1006126383"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_348.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1385/1-59259-851-x:175"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1385/1-59259-851-x:175'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1385/1-59259-851-x:175'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1385/1-59259-851-x:175'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1385/1-59259-851-x:175'


 

This table displays all metadata directly associated to this object as RDF triples.

152 TRIPLES      22 PREDICATES      103 URIs      96 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1385/1-59259-851-x:175 schema:about anzsrc-for:06
2 anzsrc-for:0604
3 schema:author Na79078f18d8144a3ad0cecd80740738d
4 schema:datePublished 2005
5 schema:datePublishedReg 2005-01-01
6 schema:description In previous studies we have shown that the level of expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor R2 was a major determinant of the sensitivity of melanoma cell lines to TRAIL-induced apoptosis. Transcriptional events regulating TRAIL death receptor expression have been the focus of much study, but our investigations point to a more important role for posttranscriptional events in regulation of TRAIL death receptors. First, although there was a wide variation in TRAIL-R2 expression between melanoma cell lines, this did not correlate with mRNA expression assessed by real-time PCR. Similarly, early passage primary cultures from patients tended to have low TRAIL-R2 protein expression compared to cells in later passage cultures, even though TRAIL-R2 mRNA expression was similar in early and late passages. Second, generation of TRAIL-resistant melanoma lines by culture in TRAIL was also associated with decreased expression of TRAIL-R2 protein, but TRAIL-R2 mRNA levels were similar to those in parental high-TRAIL-R2 expressing cells. The latter model was used to explore post-transcriptional regulation of TRAIL-R2. Expression from a luciferase reporter gene construct with the 3′ untranslated region (UTR) (but not the 5′ UTR) of TRAIL-R2 was suppressed when transfected into the TRAIL-selected (resistant) melanoma lines and in early passage (resistant) primary melanoma cultures. RNA gel shift assays demonstrated protein(s) binding to the 3′UTR but not the 5′UTR of TRAIL-R2 mRNA. These results suggest that TRAIL-R2 expression in melanoma cell lines is determined in large part by posttranscriptional events and that protein(s) binding to the 3′UTR region of TRAIL-R2 mRNA may play a key role in this regulation. Decoy receptors appeared to play little or no role in regulation of TRAIL-mediated apoptosis of melanoma.
7 schema:editor N62fabdd52f34488b9d16e1327e680797
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N6bef191edbae40babdec69bbdf13dfc0
11 schema:keywords PCR
12 R2
13 RNA gel shift assays
14 TRAIL death receptor expression
15 TRAIL death receptors
16 TRAIL receptor expression
17 TRAIL-R2
18 TRAIL-R2 expression
19 TRAIL-R2 mRNA
20 apoptosis
21 apoptosis of melanoma
22 assays
23 cell lines
24 cells
25 culture
26 death receptor expression
27 death receptors
28 decoy receptor
29 decreased expression
30 determinants
31 early passage primary cultures
32 events
33 expressing cells
34 expression
35 focus
36 gel shift assays
37 generation
38 genes
39 human melanoma
40 important role
41 investigation
42 key role
43 large part
44 late passage cultures
45 late passages
46 latter model
47 level of expression
48 levels
49 lines
50 luciferase reporter gene
51 mRNA
52 mRNA expression
53 mRNA levels
54 major determinant
55 melanoma
56 melanoma cell lines
57 melanoma cultures
58 melanoma lines
59 model
60 part
61 passage
62 passage cultures
63 patients
64 post-transcriptional regulation
65 posttranscriptional events
66 previous studies
67 primary cultures
68 primary melanoma cultures
69 protein
70 protein expression
71 real-time PCR
72 receptor R2
73 receptor expression
74 receptors
75 region
76 regulation
77 regulation of TRAIL
78 reporter gene
79 results
80 role
81 sensitivity
82 shift assays
83 study
84 trails
85 transcriptional events
86 untranslated region
87 variation
88 wide variation
89 schema:name Regulation of Trail Receptor Expression in Human Melanoma
90 schema:pagination 175-187
91 schema:productId N38653a0925c94acbb2cacea688774aa7
92 N4287f338191a412fb18a570a2350ab55
93 schema:publisher N73e181683e5f4a798405dd63ed1eff62
94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006126383
95 https://doi.org/10.1385/1-59259-851-x:175
96 schema:sdDatePublished 2022-09-02T16:14
97 schema:sdLicense https://scigraph.springernature.com/explorer/license/
98 schema:sdPublisher Nbac5b512f3d2421f937be66bb46bea52
99 schema:url https://doi.org/10.1385/1-59259-851-x:175
100 sgo:license sg:explorer/license/
101 sgo:sdDataset chapters
102 rdf:type schema:Chapter
103 N0205b6d592b74d6c8e57495ff41a75bc schema:affiliation grid-institutes:grid.266842.c
104 schema:familyName Zhang
105 schema:givenName Si Yi
106 rdf:type schema:Person
107 N2192477074d145e0a97f4da084e11f3d schema:familyName El-Deiry
108 schema:givenName Wafik S.
109 rdf:type schema:Person
110 N38653a0925c94acbb2cacea688774aa7 schema:name dimensions_id
111 schema:value pub.1006126383
112 rdf:type schema:PropertyValue
113 N4287f338191a412fb18a570a2350ab55 schema:name doi
114 schema:value 10.1385/1-59259-851-x:175
115 rdf:type schema:PropertyValue
116 N62fabdd52f34488b9d16e1327e680797 rdf:first N2192477074d145e0a97f4da084e11f3d
117 rdf:rest rdf:nil
118 N6bef191edbae40babdec69bbdf13dfc0 schema:isbn 978-1-58829-172-1
119 978-1-59259-851-9
120 schema:name Death Receptors in Cancer Therapy
121 rdf:type schema:Book
122 N73e181683e5f4a798405dd63ed1eff62 schema:name Springer Nature
123 rdf:type schema:Organisation
124 Na79078f18d8144a3ad0cecd80740738d rdf:first sg:person.01073667716.42
125 rdf:rest Nd9c6ec0dcade42db8c2f019d71d84dea
126 Nb68b2b4810ea47ecbde4c975a5aa6c7e rdf:first sg:person.01210116316.18
127 rdf:rest rdf:nil
128 Nbac5b512f3d2421f937be66bb46bea52 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 Nd9c6ec0dcade42db8c2f019d71d84dea rdf:first N0205b6d592b74d6c8e57495ff41a75bc
131 rdf:rest Nb68b2b4810ea47ecbde4c975a5aa6c7e
132 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
133 schema:name Biological Sciences
134 rdf:type schema:DefinedTerm
135 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
136 schema:name Genetics
137 rdf:type schema:DefinedTerm
138 sg:person.01073667716.42 schema:affiliation grid-institutes:grid.266842.c
139 schema:familyName Hersey
140 schema:givenName Peter
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42
142 rdf:type schema:Person
143 sg:person.01210116316.18 schema:affiliation grid-institutes:grid.266842.c
144 schema:familyName Zhang
145 schema:givenName Xu Dong
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18
147 rdf:type schema:Person
148 grid-institutes:grid.266842.c schema:alternateName David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia
149 Immunology and Oncology Unit, David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia
150 schema:name David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia
151 Immunology and Oncology Unit, David Maddison Building, University of Newcastle, Newcastle, New South Wales, Australia
152 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...